BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23275647)

  • 1. Prospective feasibility study to evaluate neoadjuvant-synchronous S-1 + RT for locally advanced rectal cancer: a multicenter phase II trial (UMIN ID: 03396).
    Inomata M; Akagi T; Nakajima K; Etoh T; Shiraishi N; Tahara K; Matsumoto T; Kinoshita T; Fujii K; Shiromizu A; Kubo N; Kitano S
    Jpn J Clin Oncol; 2013 Mar; 43(3):321-3. PubMed ID: 23275647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preoperative chemoradiotherapy with S-1 for advanced low rectal cancer].
    Kitani K; Okajima K; Sato K; Isono S; Kimura H; Ikeda M; Inoue K; Iwama M; Tsujie M; Nakayama T; Fujiwara Y; Murata M; Yukawa M; Ota Y; Inoue M
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2122-4. PubMed ID: 22202303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of neoadjuvant chemotherapy with XELOX plus bevacizumab for locally advanced rectal cancer.
    Uehara K; Ishiguro S; Sakamoto E; Maeda A; Inoue M; Tojima Y; Kobayashi S; Omiya N; Ishizuka N; Nakao A; Goto H; Nagino M
    Jpn J Clin Oncol; 2011 Aug; 41(8):1041-4. PubMed ID: 21803876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I/II study of preoperative concurrent chemoradiotherapy with S-1 for locally advanced, resectable rectal adenocarcinoma.
    Sadahiro S; Suzuki T; Tanaka A; Okada K; Kamijo A; Murayama C; Akiba T; Nakayama Y
    Oncology; 2011; 81(5-6):306-11. PubMed ID: 22156392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case report of locally advanced rectal carcinoma effectively treated with preoperative chemoradiotherapy].
    Kitani K; Okajima K; Kimura H; Ikeda M; Inoue K; Iwama M; Nakayama T; Fujiwara Y; Murata M; Yukawa M; Ishikawa K; Ota Y; Inoue M
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2635-7. PubMed ID: 21224663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot feasibility study of neoadjuvant chemoradiotherapy with S-1 in patients with locally advanced gastric cancer featuring adjacent tissue invasion or JGCA bulky N2 lymph node metastases.
    Inoue T; Yachida S; Usuki H; Kimura T; Hagiike M; Okano K; Suzuki Y
    Ann Surg Oncol; 2012 Sep; 19(9):2937-45. PubMed ID: 22466666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A resected case of pathologically complete response of a pelvic recurrence from rectal cancer after chemoradiotherapy with S-1].
    Nakano D; Matsumoto H; Yamaguchi T; Iwasaki Y; Ohashi M; Iwanaga T; Takahashi K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2137-9. PubMed ID: 20037348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of long-term survival after curative resection of advanced rectal cancer treated by pre-operative chemoradiotherapy].
    Okazaki S; Ohtsukasa S; Nakajima Y; Kamiya A; Nagano H; Takamatsu S; Kawachi Y; Maruyama H
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2256-8. PubMed ID: 22202347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irinotecan and S-1 neoadjuvant chemoradiation therapy in patients with advanced rectal cancer.
    Sato T; Kokuba Y; Koizumi W; Ozawa H; Nakamura T; Ihara A; Ootani Y; Watanabe M
    Hepatogastroenterology; 2007; 54(77):1391-3. PubMed ID: 17708261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative chemoradiotherapy with oxaliplatin and tegafur-uracil in locally advanced rectal cancer: pathologic complete response rate and preliminary results of overall and disease-free survival in a single institute in Taiwan.
    Chao JY; Wang HM; Chiang FF; Lin JC; Chang CF; Lin JF; Yeh HL
    J Chin Med Assoc; 2014 Mar; 77(3):128-32. PubMed ID: 24398439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative radiotherapy combined with S-1 for advanced lower rectal cancer: phase I trial.
    Morimoto S; Shimada M; Kurita N; Sato H; Iwata T; Nishioka M; Yoshikawa K; Miyatani T; Kashihara H; Takasu C; Ikushima H
    Hepatogastroenterology; 2012; 59(117):1428-32. PubMed ID: 22155856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of pathological complete response of advanced rectal cancer to preoperative chemoradiotherapy using S-1.
    Tanishima H; Horiuchi T; Tamagawa K; Tsujimoto T; Miyagawa Y; Ishida K; Uemura R; Hama T; Sakaguchi S; Shono Y; Tsubakihara H; Tabuse K
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1397-400. PubMed ID: 20647736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of modified short-course radiotherapy combined with a chemoradiosensitizer for T3 rectal cancer.
    Beppu N; Matsubara N; Kakuno A; Doi H; Kamikonya N; Yamanaka N; Yanagi H; Tomita N
    Dis Colon Rectum; 2015 May; 58(5):479-87. PubMed ID: 25850834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neoadjuvant chemoradiation therapy for locally advanced rectal cancer].
    Sato T; Ozawa H; Kisyu K; Kumamoto H; Nakamura T; Onozato W; Yamanashi T; Kokuba Y; Ihara A; Watanabe M
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1553-6. PubMed ID: 17940371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of a multicenter phase II study of preoperative chemoradiotherapy with S-1 plus oxaliplatin for locally advanced rectal cancer (JACCRO CC-04: SHOGUN Trial).
    Kondo K; Matsusaka S; Ishihara S; Horie H; Uehara K; Oguchi M; Murafushi K; Ueno M; Mizunuma N; Shimbo T; Kato D; Okuda J; Hashiguchi Y; Nakazawa M; Sunami E; Kawai K; Yamashita H; Okada T; Ishikawa Y; Fujii M; Nakajima T
    Radiother Oncol; 2019 May; 134():199-203. PubMed ID: 31005216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of a patient with advanced rectal cancer and urinary bladder fistula surviving for 6 years after chemoradiotherapy without surgery].
    Kimura M; Kuroda D; Kawada K; Matsushita H; Nishimura T; Shimokawa Y; Arakawa A; Soh M; Date K
    Gan To Kagaku Ryoho; 2014 Aug; 41(8):1017-20. PubMed ID: 25132037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase II trial of neoadjuvant preoperative chemoradiotherapy with S-1 plus irinotecan and radiation in patients with locally advanced rectal cancer: clinical feasibility and response rate.
    Sato T; Ozawa H; Hatate K; Onosato W; Naito M; Nakamura T; Ihara A; Koizumi W; Hayakawa K; Okayasu I; Yamashita K; Watanabe M
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):677-83. PubMed ID: 21035953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter rectal arterial chemoembolization with oxaliplatin plus S-1 concurrent chemoradiotherapy can improve the pathological remission rate in locally advanced rectal cancer: a comparative study.
    Yang B; Shan J; Feng Y; Dai N; Li M; Chen C; He S; Wang G; Xiao H; Li C; Wang D
    Radiat Oncol; 2020 May; 15(1):94. PubMed ID: 32375814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A randomized controlled trial to evaluate the effect of adjuvant oral fluoropyrimidine derivative therapy after curative resection for stage II/III rectal cancer-adjuvant chemotherapy trial of S-1 for rectal cancer (ACTS-RC):].
    Oki E; Kakeji Y; Yoshida R; Ikeda K; Nishida K; Koga T; Egashira A; Tokunaga E; Morita M; Baba H; Maehara Y
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():138-43. PubMed ID: 16897990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.